Target drug monitoring: a cost-effective service provided by staff pharmacists.Hosp Pharm. 1994 Apr; 29(4):347, 350-2.HP
Abstract
A concurrent drug use evaluation program that improves patient care while meeting JCAHO requirements was designed and implemented. Integration of staff pharmacists into the program has been an important component. The net annual savings of the program for H2 antagonists and cephalosporins was $16,756. The net annual cost of the program if all drugs were studied throughout each quarter would be $1,336. The program essentially pays for itself, meets medication use standards for JCAHO, and may save significant healthcare costs if potential drug misadventures are avoided.
MeSH
Pub Type(s)
Journal Article
Language
eng
PubMed ID
10133463
Citation
Chrymko, M M., et al. "Target Drug Monitoring: a Cost-effective Service Provided By Staff Pharmacists." Hospital Pharmacy, vol. 29, no. 4, 1994, pp. 347, 350-2.
Chrymko MM, Meyer JD, Kelly WN. Target drug monitoring: a cost-effective service provided by staff pharmacists. Hosp Pharm. 1994;29(4):347, 350-2.
Chrymko, M. M., Meyer, J. D., & Kelly, W. N. (1994). Target drug monitoring: a cost-effective service provided by staff pharmacists. Hospital Pharmacy, 29(4), 347, 350-2.
Chrymko MM, Meyer JD, Kelly WN. Target Drug Monitoring: a Cost-effective Service Provided By Staff Pharmacists. Hosp Pharm. 1994;29(4):347, 350-2. PubMed PMID: 10133463.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Target drug monitoring: a cost-effective service provided by staff pharmacists.
AU - Chrymko,M M,
AU - Meyer,J D,
AU - Kelly,W N,
PY - 1994/4/1/pubmed
PY - 1999/4/2/medline
PY - 1994/4/1/entrez
SP - 347, 350-2
JF - Hospital pharmacy
JO - Hosp Pharm
VL - 29
IS - 4
N2 - A concurrent drug use evaluation program that improves patient care while meeting JCAHO requirements was designed and implemented. Integration of staff pharmacists into the program has been an important component. The net annual savings of the program for H2 antagonists and cephalosporins was $16,756. The net annual cost of the program if all drugs were studied throughout each quarter would be $1,336. The program essentially pays for itself, meets medication use standards for JCAHO, and may save significant healthcare costs if potential drug misadventures are avoided.
SN - 0018-5787
UR - https://www.unboundmedicine.com/medline/citation/10133463/Target_drug_monitoring:_a_cost_effective_service_provided_by_staff_pharmacists_
DB - PRIME
DP - Unbound Medicine
ER -